- In August 2026, Amprius Technologies, Inc. raised its full‑year 2026 outlook, now expecting at least US$140 million in revenue and a net loss under US$10 million (or under US$0.08 per share), while also reporting second‑quarter sales of US$34.03 million and a reduced net loss of US$3.15 million.
- The combination of stronger sales growth and narrower losses suggests Amprius is scaling its business more efficiently, potentially reinforcing confidence in its commercial battery model and long‑term production plans.
- With Amprius lifting full‑year revenue guidance, we’ll examine how this improved outlook reshapes the company’s existing investment narrative.
Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
Amprius Technologies Investment Narrative Recap
To own Amprius, you need to believe its high energy density batteries can move from niche aviation and drones into broader, higher volume markets while turning today’s losses into durable profitability. The upgraded 2026 outlook and improving Q2 results support the near term catalyst of scaling revenue without ballooning losses, but they do not remove the key risks around heavy end market concentration and the technical and operational challenge of ramping silicon anode production at larger scale.
The most relevant recent development here is the higher full year 2026 guidance to at least US$140 million in revenue with a net loss under US$10 million. Against earlier guidance from March, this points to stronger than expected top line traction while keeping losses relatively contained, which directly ties into the core catalyst of Amprius proving it can scale volume through contract manufacturers and new customers without eroding its path toward better margins.
Yet against this improving outlook, investors should still be aware of how exposed Amprius remains to concentrated end markets and potential production hiccups...
Read the full narrative on Amprius Technologies (it's free!)
Amprius Technologies’ narrative projects $415.0 million revenue and $53.6 million earnings by 2029. This requires 66.3% yearly revenue growth and a $93.3 million earnings increase from -$39.7 million today.
Uncover how Amprius Technologies' forecasts yield a $22.12 fair value, a 77% upside to its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were already assuming Amprius could reach about US$515.0 million of revenue and over US$100 million of earnings by 2029, which is far more bullish than the consensus view that emphasizes current losses and scale up risk; with the new 2026 guidance, you now have to decide whether this kind of defense driven growth story looks more realistic or still too aggressive.
Explore 10 other fair value estimates on Amprius Technologies - why the stock might be worth over 2x more than the current price!
Form Your Own Verdict
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Amprius Technologies research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
- Our free Amprius Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Amprius Technologies' overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
Our top stock finds are flying under the radar-for now. Get in early:
- Find 52 companies with promising cash flow potential yet trading below their fair value.
- AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com